Pituitary Tumor Surveillance: Pathogenic Correlation
NCT00599092 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1250
Last updated 2026-03-23
Summary
The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.
Conditions
- Pituitary Tumor
Sponsors & Collaborators
-
Cedars-Sinai Medical Center
lead OTHER
Principal Investigators
-
Shlomo Melmed, MD · Cedars-Sinai Medical Center, Pituitary Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1997-01-31
- Primary Completion
- 2050-12-31
- Completion
- 2050-12-31
Countries
- United States
Study Locations
More Related Trials
-
Prediction of Sphenoid Septation in MRI Compared With CT and Intraoperative Findings During Endoscopic Pituitary Adenoma Surgery
NCT03624114 ·Status: COMPLETED
-
The Predictive Factors of Vision Recovery in Patients With Pituitary Tumor
NCT01377701 ·Status: UNKNOWN
-
Predictive Value of Serum and Tissue Molecular Markers and Imaging Features in the Invasiveness and Prognosis of Pituitary Neuroendocrine Tumors
NCT06015802 ·Status: RECRUITING
-
Predictive Factors for Survival in Aggressive Meningiomas
NCT05793034 ·Status: RECRUITING ·Phase: NA
-
Endocrine Outcome of Surgery for Pituitary Adenoma
NCT03515603 ·Status: TERMINATED ·Phase: NA
-
A Research Registry on Aggressive PitNETs
NCT05974696 ·Status: RECRUITING
-
Predictive Factors of Recurrence of Non Functioning Pituitary Adenomas : a Retrospective Study of 220 Patients in the Reims University Hospital, France
NCT02803697 ·Status: COMPLETED
-
Natural History of Patients With Brain and Spinal Cord Tumors
NCT00009035 ·Status: COMPLETED
-
Genome-wide Association Study of Pituitary Tumors
NCT01442220 ·Status: UNKNOWN
-
Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH)
NCT01903967 ·Status: COMPLETED
-
Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
NCT05692635 ·Status: RECRUITING ·Phase: PHASE2
-
Characterization of Receptors in Non-functioning Pituitary Macroadenomas
NCT00852501 ·Status: UNKNOWN
-
Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
NCT06954636 ·Status: RECRUITING
-
Molecular and Cellular Characterization of Skull Base Tumors
NCT03759717 ·Status: RECRUITING
-
Comparative Study Between Different Approaches to CPA-petroclival Meningiomas
NCT03462914 ·Status: UNKNOWN
-
Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery
NCT03678389 ·Status: RECRUITING ·Phase: NA
-
Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus
NCT02536261 ·Status: UNKNOWN
-
Evaluation of Cavernous Sinus Invasion by Pituitary Adenoma Using Deep Learning Based Denoising MR
NCT04268251 ·Status: COMPLETED ·Phase: NA
-
DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma
NCT00899834 ·Status: COMPLETED
-
Predictive Factors of Visual Recovery After Paraoptic Tumors Removal
NCT03567486 ·Status: COMPLETED
-
The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction
NCT06874426 ·Status: RECRUITING
-
Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy
NCT02913534 ·Status: COMPLETED
-
Molecular Imaging of Pituitary Adenomas
NCT03815838 ·Status: UNKNOWN ·Phase: NA
-
A Family Study of Adults With Glioma
NCT00339352 ·Status: COMPLETED
-
Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors
NCT00005790 ·Status: WITHDRAWN ·Phase: NA